Asthma update: Part II. Medical management.
Mintz
Matthew
M
The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
D000085:Acetates / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011804:Quinolines / Q000627:therapeutic use; D012129:Respiratory Function Tests; D013440:Sulfides
D000085:Acetates; D000318:Adrenergic beta-Agonists; D000900:Anti-Bacterial Agents; D003521:Cyclopropanes; D005938:Glucocorticoids; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast